stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 9.31

+0.07 (+0.76)%

USD 0.34B

0.28M

USD 23.00(+147.05%)

USD 12.00 (+28.89%)

Icon

ZYXI

Zynex Inc (USD)
COMMON STOCK | NSD
USD 9.31
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 0.34B

USD 12.00 (+28.89%)

USD 9.31

Zynex Inc Stock Forecast

USD 23.00
(+147.05%)

Based on the Zynex Inc stock forecast from 2 analysts, the average analyst target price for Zynex Inc is USD 23.00 over the next 12 months. Zynex Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Zynex Inc is Slightly Bullish , which is based on 11 positive signals and 5 negative signals. At the last closing, Zynex Inc’s stock price was USD 9.31. Zynex Inc’s stock price has changed by -0.96% over the past week, -0.64% over the past month and +30.39% over the last year.

No recent analyst target price found for Zynex Inc
No recent average analyst rating found for Zynex Inc

Company Overview

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality i...Read More

https://www.zynex.com

9655 Maroon Circle, Englewood, CO, United States, 80112

900

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Zynex Inc (Sector: Medical Distribution )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HSIC
Henry Schein Inc +0.84 (+1.13%) USD9.75B 21.02 11.35

ETFs Containing ZYXI

Symbol Name ZYXI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About ZYXI Stock

Based on ratings from 2 analysts Zynex Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on ZYXI's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for ZYXI is USD 23.00 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 18.

ZYXI stock's Price/Earning ratio is 21.00. Our analysis grades ZYXI stock's Price / Earning ratio at C. This means that ZYXI stock's Price/Earning ratio is above 25% of the stocks in the Medical Distribution sector in the NSD exchange. Based on this ZYXI may be undervalued for its sector.

The last closing price of ZYXI's stock was USD 9.31.

The most recent market capitalization for ZYXI is USD 0.34B.

Based on targets from 2 analysts, the average taret price for ZYXI is projected at USD 23.00 over the next 12 months. This means that ZYXI's stock price may go up by +147.05% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...